C19ORF2-CHD4 Fusion FISH Probe
The C19ORF2-CHD4 Fusion FISH Probe is used to confirm a fusion of the C19ORF2 and CHD4 genes. The fusion of the C19ORF2 and CHD4 genes has been associated with Sarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| C19ORF2-CHD4-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-RERE | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-REOR | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-REGO | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-REGR | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-OROR | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GORE | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GROR | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| C19ORF2-CHD4-20-AQAQ | 20 (40 μL) | 200 μL |
|
CHD4 Gene Summary
The product of this gene belongs to the SNF2/RAD54 helicase family. It represents the main component of the nucleosome remodeling and deacetylase complex and plays an important role in epigenetic transcriptional repression. Patients with dermatomyositis develop antibodies against this protein. Somatic mutations in this gene are associated with serous endometrial tumors. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
Gene Name: Chromodomain Helicase DNA Binding Protein 4
Chromosome: CHR12: 6679247 -6716551
Locus: 12p13.31
Gene Diseases
The C19ORF2 CHD4 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Sarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|